Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 62Active not recruiting 25Not yet recruiting 21Completed 7Terminated 5Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vaping 1Smoking 1Neoplasms 1Colorectal Neoplasms 1

Interventions

Educational Status 5Interviews as Topic 4Methods 3Early Intervention, Educational 3Cisplatin 3Blood Specimen Collection 3pembrolizumab 2Surveys and Questionnaires 2Standard of Care 2Nivolumab 2Music Therapy 2Magnetic Resonance Imaging 2Gemcitabine 2Counseling 2zilucoplan 1tislelizumab 1somapacitan 1sacituzumab govitecan 1rozanolixizumab 1oxycodone-acetaminophen 1ibrutinib 1futibatinib 1fluorodopa F 18 1erdafitinib 1enzalutamide 1enfortumab vedotin 1dynorphin-converting endopeptidase 1durvalumab 1dalpiciclib 1brexucabtagene autoleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Standard of Care × 90 days × Clear all
NCT06822530 2026-06-04

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Fred Hutchinson Cancer Center

Phase NA Enrolling by invitation
682 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07039292 2026-05-08

CARE

Medical University of South Carolina

Phase NA Enrolling by invitation
208 enrolled

Vaping, Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡